tm logo
THE FUTURE OF MEDICINE IS ACELLULAR BIOLOGICS
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 11 Jun 2024

Last Applicant/ Owned by

1972 Mac Gregor Road

Tarpon Springs

FL

34689

Serial Number

98188607 filed on 20th Sep 2023

Registration Number

N/A

Correspondent Address

DES MOINES, IA 50309-2721

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

THE FUTURE OF MEDICINE IS ACELLULAR BIOLOGICS

Development of biomedical and pharmaceutical products, preparations and medicines; pharmaceutical and biomedical product evaluation; research and development services in the field of medical preparations, biologics, and regenerative medicine and consultancy services relating thereto; scientific investigations for medical purposes; laboratory research in the field of regenerative medicine, biomedic Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Development of biomedical and pharmaceutical products, preparations and medicines; pharmaceutical and biomedical product evaluation; research and development services in the field of medical preparations, biologics, and regenerative medicine and consultancy services relating thereto; scientific investigations for medical purposes; laboratory research in the field of regenerative medicine, biomedical products, and pharmaceuticals; medical laboratory services and scientific laboratory services; biomedical research services; biotechnology research; chemical research; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; drug discovery services; industrial research in the field of regenerative and reparative therapies; medical research; pharmaceutical drug development services; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields; scientific research and development; technology research in the field of regenerative and reparative therapies; pharmaceutical, medical, and scientific research and development services in the fields of cell therapy, gene therapy, oncology, immunotherapy, and regenerative medicine; scientific research for medical purposes in the area of regenerative medicine, wound repair, surgical repair, and nerve repair and regeneration; providing medical and scientific research information relating to medical treatment in the nature of results of scientific research and clinical data in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration; clinical research in the areas of regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and pharmaceutical preparations and delivery systems, to provide information on functional recovery and treatment outcomes; research and development of new products and procedures in the pharmaceutical and biotechnology fields; development of new technology for others in the fields of pharmaceutical preparations and delivery systems therefor, regenerative medicine, wound repair, surgical repair, nerve repair and regeneration, and tissue generation, processing and transplantation; scientific and technological services and research and design relating thereto, namely, medical research, scientific research and analysis in the fields of pharmaceuticals and biomedicine; pharmaceutical, biomedical and biological therapeutic research services; scientific research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials; pharmaceutical research and development; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials pharmaceutical research and development services; medical and scientific research information in the field of novel pharmaceutical discovery and development; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the field of novel pharmaceutical treatments and clinical trials; providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [035]
Advertising, Business & Retail Services


Wholesale, online retail, retail store, and catalog ordering services featuring medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; distributorship services in the field of medical biomaterials, pharmaceutical drugs, pharmaceutical preparations, and regenerative medicines; wholesale services by direct solicitation by sales agents in the field of pharmaceutical, regenerative medicine products, and biologics; publicity and sales promotion relating to goods and services; on-line wholesale and retail store services featuring pharmaceutical, regenerative medicine products, and biologics, also accessible by telephone, facsimile, and mail order; and wholesale store services for pharmaceutical preparations and medical supplies


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Providing technical information in the field of manufacturing biomaterials, pharmaceuticals, regenerative medicine products, and biologics, and their manufacturing; processing of medical materials, namely, custom fabrication, and assembly of biologics for research, development, and medical purposes; biologic manufacturing for others, namely, isolating and processing biologic tissue products from human placental and birth tissues for use in regenerative medicine; biologic manufacturing, namely, isolating and processing biologic products from human placental and birth tissues for use in regenerative medicine; custom manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics for others; biomanufacturing for others, namely, manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics, pharmaceuticals, regenerative medicine products, and biologics using biological materials in the manufacturing process; technical consulting related to the manufacturing of biomaterials, pharmaceuticals, regenerative medicine products, and biologics; treatment of materials for the manufacture of biomaterials, pharmaceuticals, regenerative medicine products, and biologics; processing of biomaterials for use in manufacture of pharmaceuticals, regenerative medicine products, and biologics; cryogenic preservation services of biologics; processing of medical materials, namely, custom fabrication, and assembly of biologics for therapeutic purposes; sterilizing of human amniotic fluid; and biologic manufacturing, namely, isolating and processing biologic tissue products from human placental and biologic birth tissues for use in regenerative medicine


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, ophthalmic, ocular disorders or diseases, eye diseases and conditions, respiratory, neurological, gastrointestinal, hormonal, dermatological, skin damage and disorders, tissue damage and disorders, soft tissue and wounds, immune system related diseases and disorders, central and peripheral nervous system, tendon and muscle injuries and disorders, and sports related injuries; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products for the prevention and treatment of cancer, and suppressing tumors; pharmaceutical products for regenerative medicine; biologically derived products developed from perinatal tissue and fluid material for medical and medical regenerative purposes; bioengineered placental biomaterials; biologics; tissue-regenerative medical preparations; therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for use in the treatment of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; therapeutic pharmaceuticals for changing immune response and improving regenerative capacities for the prevention of medical conditions and diseases, namely, cancer, blood diseases, infectious diseases, and autoimmune diseases; and pharmaceutical preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98188607

Mark Type

No Service Mark

Attorney Docket Number

No T60211US00

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Jun 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
11th Jun 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
26th Feb 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
26th Feb 2024NON-FINAL ACTION E-MAILED
26th Feb 2024NON-FINAL ACTION WRITTEN
09th Feb 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
09th Feb 2024NON-FINAL ACTION E-MAILED
09th Feb 2024NON-FINAL ACTION WRITTEN
02th Feb 2024ASSIGNED TO EXAMINER
05th Oct 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED